James C. Czirr, Executive Chairman at GALECTIN THERAPEUTICS INC (GALT), sold 112,000 shares at $11.79 ($1.3M) on 2013-10-07, disclosed to the SEC on 2013-10-09.
Open-market sale of $1.3M GALT by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.79 | 100,000 | $1.2M | 88.8% |
| 2 | $12.36 | 12,000 | $148K | 11.2% |
| Total | $11.85 avg | 112,000 | $1.3M | 100% |
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |